Warning letters, 483s, Recalls, Import Alerts, Audit observations
Novo Nordisk owned Catalent Indiana sterile products formulation facility was inspected by USFDA in June
The USFDA has issued a Warning Letter to Shiva Analyticals’ Bangalore facility following significant cGMP
Natco Pharma’s sterile products manufacturing facility at Rangareddy, Telengana (FEI 3004540906) was inspected by USFDA
The USFDA issued a notification on 22 May, 2025 on Data Integrity concerns on reliability
The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Aspen Biopharma Labs
The U.S. FDA issued a warning letter to International Laboratories Corp. (FEI 3006403166) following CGMP
Granules India received a warning letter from the USFDA in February 2025. This was along
Indian API manufacturer Global Calcium Pvt Ltd was issued a Warning letter by USFDA in
Authored by: Venkiteswaran.T.K, Srinivas Churya FDA has published the Warning Letter issued to the Viatris Pithampur facility in December
New Delhi based Unexo Life Sciences has initiated a major recall of several medicated patch
